Introduction {#s01}
============

Polarized cell shape changes provide forces that alter the morphology of tissues, organs, and embryos. For example, changes in the shapes of *Caenorhabditis elegans* epidermal cells transform the embryo from an ellipse into an elongated worm-shaped cylinder in the absence of cell division. Epidermal cells are born on the dorsal surface of the embryo, then migrate ventrally and form new junctions with contralateral epidermal cells to wrap the embryo in skin ("ventral enclosure"; [@bib12]; [@bib91]). After completing ventral enclosure, epidermal cells begin to lengthen along their anterior-posterior axis and simultaneously shrink along their dorsal-ventral axis ("elongation"; [Fig. 1 A](#fig1){ref-type="fig"}). Actomyosin contractions in lateral epidermal cells provide the forces that alter epidermal cell shape during the early stage of elongation ([@bib5]; [@bib16]; [@bib91]). Subsequently, the contraction of underlying muscles attached to epidermal cells provides forces that allow elongation to continue up to the fourfold stage ([@bib5]; [@bib16]; [@bib91]). It is unclear how epidermal cells regulate adherens junctions (AJs) and their associated microfilaments during elongation to allow the remodeling needed for these asymmetric cell shape changes while still preserving cell adhesion. This problem is common to all types of epithelial cells that alter their shapes or change positions relative to neighbors during morphogenesis ([@bib13]; [@bib77]).

![***cdc-42* embryos have defects in ventral enclosure and elongation.** (A) Stages of embryo elongation: bean stage (pre-elongation), comma stage (1.4-fold), and pretzel stage (\>3-fold). Junctions between epidermal cells are indicated with black lines. Lateral epidermal cells ("seam" cells) are yellow. Double-headed arrows indicate the extension in anterior-posterior length of a cell as the embryo elongates. (B and C) Stills from DIC time-lapse movies of control and *cdc-42(MZ)* embryos shown at 30-min intervals. Genotypes were confirmed by single-embryo PCR after imaging. Arrows in C point to extruding cells. See Video 1. (D) Phenotypic classes of arrested embryos from DIC time-lapse imaging experiments (*n* = 39). (E) Rates of elongation in control (*n* = 13) and Class III (*n* = 9) embryos. Fold elongation was measured as schematized. *t* = 0 represents the comma stage. Values are the mean ± SD. Data for D and E were pooled from eight independent imaging experiments. P-values were calculated using a Mann-Whitney *U* test. \*\*\*, P ≤ 0.001. Bars, 5 µm.](JCB_201611061_Fig1){#fig1}

*C. elegans* AJs contain highly conserved components, including the transmembrane homophilic adhesion protein HMR-1/E-cadherin and the cytoplasmic catenins HMP-1/α-catenin and HMP-2*/*β-catenin, which interact with the HMR-1/E-cadherin cytoplasmic tail and link it to actin microfilaments ([@bib14]; [@bib44]; [@bib47]). Null mutations in *hmr-1/E-cadherin*, *hmp-1/α-catenin*, or *hmp-2/β-catenin* cause microfilaments to detach from AJs as epidermal cells elongate, leading to developmental arrest and epidermal rupture ([@bib14]). In addition to α-catenin and β-catenin, the p120 catenin JAC-1 also binds to the cytoplasmic tail of HMR-1/E-cadherin ([@bib67]). Although JAC-1 is not essential in *C. elegans* ([@bib42]), its depletion enhances the phenotype of weak mutations in *hmp-1* ([@bib67]), indicating that JAC-1 is an important regulator of AJ function.

AJs form through a two-step process of polarization and junction maturation. These events occur during the middle of embryogenesis, when epithelial precursor cells undergo a mesenchymal-to-epithelial transition (MET). During the polarization step of MET, clusters of AJ proteins found along the lateral membrane concentrate at the apicolateral region of the cell ([@bib51]; [@bib60]; [@bib2]). Concomitantly, polarity regulators begin to occupy distinct subdomains at the cell surface: the adaptor protein PAR-6 localizes apically, the scaffolding protein PAR-3 concentrates at AJs, the Discs large homologue DLG-1 accumulates at the basal side of AJs, and the Scribble protein LET-413 localizes to basolateral surfaces ([@bib49]; [@bib10]; [@bib27]; [@bib43]; [@bib60]; [@bib4]; [@bib2]). Whereas PAR-3 mediates polarization of other epithelial cell types in *C. elegans* ([@bib43]; [@bib4]; [@bib2]), epidermal cells polarize through an unknown PAR-3--independent mechanism. Junction maturation requires PAR-6, DLG-1, and LET-413; embryos lacking any of these polarity regulators arrest during elongation ([@bib49]; [@bib10]; [@bib27]; [@bib43]; [@bib60]; [@bib86]).

One important regulator of AJs that has not been examined during epidermal cell MET or elongation is the Rho GTPase CDC-42. Active CDC-42 can interface with PAR proteins by binding directly to the PAR-6 CRIB (CDC-42/Rac interactive binding) domain ([@bib31]; [@bib1]), and interfering with CDC-42 function in many epithelial cell types disrupts polarity or the turnover of AJ components, leading to epithelial defects ([@bib83]; [@bib21]; [@bib55]). For example, *Cdc42* is required for apical membrane differentiation in the blastoderm of *Drosophila melanogaster* embryos ([@bib36]) and in epithelial MDCK cells grown in 3D culture ([@bib59]). Removing *Cdc42* in fully polarized *Drosophila* epithelia causes defects in AJ organization by altering endocytosis or exocytosis, depending on the tissue ([@bib29]; [@bib32]; [@bib50]). CDC-42 can also regulate junction stability by controlling actin polymerization and turnover. For instance, multiple actin-nucleating factors, such as the Arp2/3 complex and formins, function downstream of CDC-42 to influence F-actin organization at junctions ([@bib65]; [@bib89]; [@bib68]; [@bib72]). In turn, junctional F-actin can modulate AJs by affecting endocytosis, or by physically controlling E-cadherin clustering ([@bib13]; [@bib87]; [@bib94]).

Because CDC-42 is widely distributed in cells and regulates many different events ([@bib26]), its activity at specific subcellular locations is often locally controlled. Like other Rho GTPases, CDC-42 is active when bound to GTP and inactive when bound to GDP. RhoGEFs activate CDC-42 and other Rho GTPases by promoting GTP binding, whereas RhoGAPs function as inhibitors by promoting GTP hydrolysis ([@bib9]). Studies using constitutively active and dominant negative versions of CDC-42 have shown that its activity must be regulated to ensure normal junction formation and maintenance ([@bib45]; [@bib76]; [@bib11]; [@bib22]), indicating that RhoGEFs and RhoGAPs are likely to influence CDC-42 activity at junctions. In cultured mammalian epithelial cells, CDC-42 activity is tuned at different stages of junction biogenesis by a small number of GEFs and GAPs, including the RhoGEFs Tuba and Dbl3/ARHGEF21 ([@bib65]; [@bib95]) and the RhoGAPs Rich1 and SH3BP1 ([@bib93]; [@bib22]). However, it remains unclear which RhoGEFs or RhoGAPs function in vivo to regulate CDC-42 activity as junctions remodel during morphogenesis.

Here, we show that, unexpectedly, CDC-42 is dispensable for polarization and junction maturation during MET in the *C. elegans* epidermis, but is essential during elongation to control the polarized cell shape changes and junctional actin dynamics of epidermal cells. We identify the conserved RhoGAP PAC-1/ARHGAP21, which localizes specifically to AJs and likely functions with its binding partner PICC-1/CCDC85A-C, as a negative regulator of CDC-42 activity at these sites. *pac-1* mutant embryos form ectopic, dynamic, actin extensions at AJs, exhibit increased AJ protein levels, and fail to elongate in a sensitized genetic background. Our findings reveal that RhoGAP-mediated CDC-42 regulation enables tight control over actin organization and AJ protein levels in vivo, allowing epithelial cells to remodel their junctions efficiently as cells change shape.

Results {#s02}
=======

CDC-42 is required for proper ventral enclosure and embryo elongation {#s03}
---------------------------------------------------------------------

*C. elegans* has a single *cdc-42* homologue, which is expressed ubiquitously in embryos, larvae, and adults ([@bib3]; [@bib7]; [@bib64]). Within the embryo, CDC-42 protein arises from both maternal and zygotic sources. Reducing levels of maternal CDC-42 results in a loss of polarity and defects in spindle orientation in early embryos, culminating in embryonic lethality ([@bib31]; [@bib40]; [@bib3]). We examined *cdc-42* function in later embryos by using a degron-based strategy to deplete maternal CDC-42 protein from the early embryo just after its function in the one-cell embryo is complete, while simultaneously eliminating zygotic *cdc-42* expression with a *cdc-42* null allele, *gk388* ([@bib3]). Proteins tagged with the PIE-1 zinc finger 1 (ZF1) domain are recognized by the E3 ligase adaptor ZIF-1, which causes the tagged proteins to degrade rapidly from early embryonic somatic cells after the one-cell stage ([@bib73]; [@bib17]; [@bib63]). However, because ZIF-1 appears to be present only in early embryos ([@bib7]), ZF1-tagged proteins that are expressed zygotically at later embryonic stages do not degrade. CDC-42 fused at its N-terminus with HA tags and the ZF1 domain ([@bib3]) largely rescued the lethality of *cdc-42* mutants (84% \[389/463\] of *cdc-42\[gk388\]; ha-zf1-cdc-42* embryos were viable) and degraded rapidly from early embryonic somatic cells before its zygotic expression began during the middle of embryogenesis (Fig. S1, A--B; [@bib3]). To obtain embryos lacking *cdc-42* activity, we allowed *cdc-42; ha-zf1-cdc-42/+* hermaphrodites to self-fertilize (Fig. S1 C, Strategy I). One quarter of the resulting progeny should lack the *ha-zf1-cdc-42* transgene, and because the maternal HA-ZF1-CDC-42 protein is degraded, these embryos will be left with no maternal or zygotic source of CDC-42 (Fig. S1 C, right). Hereafter, we refer to such embryos as *cdc-42(MZ*). Of the self-progeny of *cdc-42; ha-zf1-cdc-42/+* heterozygotes, 24% (116/479) died before hatching. PCR genotyping showed that 84% (15/18) of randomly selected dead embryos were *cdc-42(MZ)*, whereas the remaining 16% (3/18) contained the *ha-zf1-cdc-42* transgene but failed to rescue. Thus, although *ha-zf1-cdc-42* transgene largely rescues the *cdc-42(gk388)* mutant phenotype, it does not do so completely. All healthy genotyped L1 larvae contained the *ha-zf1-cdc-42* transgene (19/19), whereas a small number of *cdc-42(MZ)* embryos died soon after hatching into sickly larvae. We conclude that *cdc-42* has an essential function during the second half of embryonic development, after zygotic *cdc-42* expression begins.

We used 3D time-lapse differential interference contrast (DIC) imaging to examine the dynamics of ventral enclosure and elongation in live *cdc-42(MZ)* embryos ([Fig. 1, B and C](#fig1){ref-type="fig"}; and Video 1). Of 135 embryos imaged from a *cdc-42; ha-zf1-cdc-42/+* mother, 39 (29%) did not hatch. Based on the results of our genotyping, 86% of unhatched embryos are predicted to be *cdc-42(MZ)* embryos, whereas the remaining small percentage of arrested embryos are predicted to contain the *ha-zf1-cdc-42* transgene. Arrested embryos were assigned to three phenotypic classes according to the final stage of morphogenesis they completed ([Fig. 1 D](#fig1){ref-type="fig"}): Class I embryos (17/39, 44%) failed to complete ventral enclosure and therefore arrested before elongation; Class II embryos ruptured in the head ventral region early in elongation, typically at the 1.5-fold stage (8/39, 20%; [Fig. 1 C](#fig1){ref-type="fig"}); Class III embryos arrested later during elongation, at or after the twofold stage, with extruded cells (14/39, 36%). Embryos that arrested during elongation also elongated at a slower rate than embryos that developed to hatching ([Fig. 1 E](#fig1){ref-type="fig"}). Based on these observations and our genotyping data, we conclude that loss of *cdc-42* activity causes significant morphogenetic defects that are apparent during ventral enclosure and elongation, and that cause embryonic arrest before elongation is complete.

CDC-42 is dispensable for polarity establishment and junction maturation {#s04}
------------------------------------------------------------------------

We next tested if there were defects in epidermal cell polarization or junction maturation in *cdc-42(MZ)* embryos that could explain their arrest phenotype. CDC-42 is thought to promote epithelial cell polarization by recruiting PAR-6 to the apical surface; this interaction occurs through the PAR-6 CRIB domain, which binds directly to active CDC-42 ([@bib37]; [@bib38]; [@bib53]; [@bib71]; [@bib31]; [@bib36]; [@bib1]). Unexpectedly, PAR-6 still accumulated at the apical membrane of epidermal cells ([Fig. 2 B](#fig2){ref-type="fig"}, red arrow) in *cdc-42(MZ)* embryos, even though the apical to cytoplasmic ratio of PAR-6 immunostaining in the epidermis of *cdc-42(MZ)* mutants was decreased twofold compared with control embryos ([Fig. 2, A, E, and F](#fig2){ref-type="fig"}). To rule out the possibility that a trace amount of HA-ZF1-CDC-42 beyond our limit of detection remained in *cdc-42(MZ)* embryos and was sufficient to recruit PAR-6, we examined the localization of a previously characterized form of PAR-6 with mutations in the CRIB domain that make it unable to bind CDC-42 ([@bib1]). PAR-6ΔCRIB-GFP, expressed from endogenous regulatory sequences and examined in a *par-6(MZ)* mutant background, localized similarly to endogenous PAR-6 in *cdc-42(MZ)* mutants, with strong apical enrichment in epithelial cells that was less pronounced but still evident in epidermal cells (compared with PAR-6-GFP in wild-type; [Fig. 2, C, D, and G](#fig2){ref-type="fig"}). However, *par-6(MZ); par-6ΔCRIB-gfp* embryos arrested before the 1.7-fold stage of elongation (27/27), in contrast with *par-6(MZ); par-6-gfp* embryos, which nearly all survived (95%, 232/243). Thus, whereas neither CDC-42 nor the PAR-6 CRIB domain is essential for PAR-6 apical enrichment, both contribute to enriching PAR-6 apically within epidermal cells, and the CRIB domain is needed for PAR-6 function.

![***cdc-42* is not required for epidermal cell polarity or junction maturation.** (A and B) PAR-6 staining of control embryos (*cdc-42* mutants rescued with *ha-zf1-cdc-42*) and *cdc-42(MZ)* embryos. Red arrows indicate PAR-6 enrichment at the apical domain in epidermis; white arrows indicate enrichment at the apical domain in intestine. Red lines show t where the intensity profile shown in E was taken. (C and D) PAR-6-GFP and PAR-6ΔCRIB-GFP imaged live in *par-6(MZ)* embryos. (E) Intensity profile of PAR-6 in control (representative of *n* = 24) and in *cdc-42(MZ)* (representative of *n* = 20) epidermal cells (taken from micrographs shown in A and B). (F) Quantification of apical membrane to cytoplasm intensity ratio of PAR-6 immunostaining in the epidermis of control (*n* = 24) and *cdc-42(MZ)* (*n* = 20) embryos. Individual data points from two independent experiments were pooled. (G) Quantification of apical membrane to cytoplasm intensity ratio in the epidermis of PAR-6-GFP (*n* = 13) and PAR-6ΔCRIB-GFP (*n* = 14) in live *par-6(MZ)* embryos. Individual data points from two independent experiments were pooled. (H--I) Frames from time-lapse movies of control and *cdc-42(MZ)* embryos expressing HMR-1-GFP, showing polarization and junction maturation of dorsal epidermal cells. Insets show a side view of lateral epidermal cells, in which apical enrichment of HMR-1-GFP to junctions is observed by 50 min. *t* = 0 is defined as the initiation of polarization, when HMR-1-GFP puncta are first detected in the intestine. See Videos 2 and 3. (J) Quantification of junctional enrichment of HMR-1-GFP in epidermal cells at *t* = 50 min (control, *n* = 9 embryos; *cdc-42(MZ)*, *n* = 12 embryos). (K and L) Immunostaining of junctional HMP-1 and basolateral LET-413 in control and *cdc-42(MZ)* embryos. Insets below are of boxed region. Line and error bars in graphs (F, G, and J) indicate mean ± SD. P-values were calculated using a Mann-Whitney *U* test. \*, P ≤ 0.05; \*\*\*, P ≤ 0.001. NS, P \> 0.05. Bars, 5 µm.](JCB_201611061_Fig2){#fig2}

Because PAR-6 is required for junction maturation, we asked whether the decreased apical enrichment of PAR-6 in *cdc-42(MZ)* epidermal cells blocked or slowed junction formation or maturation. We examined junctions when epidermal cells first polarized via MET using fluorescence time-lapse imaging of two junction proteins: the E-cadherin HMR-1-GFP expressed from a knockin allele, and the Discs large protein DLG-1-RFP expressed from an integrated transgene. To genotype live *cdc-42(MZ)* embryos, we created a functional *zf1-yfp-cdc-42* knockin allele, placed this in trans to the *cdc-42(gk388)* null mutation, and selected YFP-negative self-progeny embryos (*cdc-42\[gk388\]* homozygotes; Fig. S1 D, Strategy II). Such embryos had no detectable levels of YFP, indicating that maternal ZF1-YFP-CDC-42 degradation was efficient (Fig. S1, D and E). To visualize HMR-1-GFP during junction formation, we acquired an image stack from the dorsal surface to the center of the embryo. This allowed us to observe MET en face (in epidermal cells) and in cross section (in epidermal and intestinal cells). At initial stages of polarization in control embryos, the intensity of HMR-1-GFP was low and uneven along contacts at the apicolateral edges of epidermal cells ([Fig. 2 H](#fig2){ref-type="fig"} and Video 2). As cells polarized, HMR-1-GFP localized evenly at apicolateral AJs. Junction formation in *cdc-42(MZ)* embryos was indistinguishable from control embryos ([Fig. 2 I](#fig2){ref-type="fig"}), and the junctional to lateral ratio of HMR-1-GFP in polarized epidermal cells was not significantly different ([Fig. 2 J](#fig2){ref-type="fig"}). As in epidermal cells, intestinal epithelial cells of *cdc-42(MZ)* embryos showed normal polarization of HMR-1-GFP during MET (Video 3). We obtained similar results for DLG-1-RFP, which, like HMR-1-GFP, initially formed puncta at epithelial cell--cell contacts before puncta coalesced into a continuous apicolateral belt-like structure (Fig. S2, A--B; and Video 4).

We examined additional markers to determine if *cdc-42* is dispensable for other aspects of epidermal cell polarization. PAR-3-GFP still accumulated apically in *cdc-42(MZ)* epidermal cells, albeit with a mild but significant decrease in apical enrichment compared with wild-type (Fig. S2, C--E). Immunostaining for endogenous proteins at AJs (HMP-1), basal junctions (DLG-1), and the basolateral membrane (LET-413) did not reveal any mislocalization in *cdc-42(MZ)* mutant embryos ([Fig. 2, K and L](#fig2){ref-type="fig"}; and Fig. S2, F and G). Altogether, our live-imaging experiments with fluorescently tagged junction proteins and examination of endogenous polarity proteins in fixed embryos demonstrate that, surprisingly, *cdc-42* is not required for epidermal cell polarization or junction maturation during the process of MET.

CDC-42 regulation is important for elongation {#s05}
---------------------------------------------

We next addressed the consequences of increasing cdc-42 activity. In contrast with *cdc-42* loss of function, overexpressing *cdc-42* using a functional *gfp-cdc-42* transgene ([@bib64]) did not cause any significant defects or lethality in an otherwise wild-type background ([Table 1](#tbl1){ref-type="table"}). However, *gfp-cdc-42* overexpression decreased embryonic survival in a genetically sensitized *hmp-1(fe4)* background, which has been used to identify genes that contribute to AJ function ([@bib67]; [@bib15]; [@bib54]). The *fe4* mutation compromises the ability of HMP-1/α-catenin to bind F-actin ([@bib56]) and results in 52% of embryos arresting during elongation, whereas 48% survive through embryogenesis ([@bib67]; [Table 1](#tbl1){ref-type="table"}). However, only 19% of *hmp-1(fe4); gfp-cdc-42* embryos survived, hatching into misshapen larvae similar to *hmp-1(fe4)* larvae ([Table 1](#tbl1){ref-type="table"}). 12% of *hmp-1(fe4); gfp-cdc-42* embryos arrested at ventral enclosure (Class I), whereas the remainder developed dorsal epidermal bulges and arrested during elongation, reaching at most the twofold stage (Fig. S3, A and E; and Video 5). This enhancement of lethality was similar to that caused by overexpressing *rho-1 (RhoA)*, which also decreased survival of *hmp-1(fe4)* mutants to 19%, whereas overexpressing *ced-10 (Rac)* had no effect on *hmp-1(fe4)* lethality ([Table 1](#tbl1){ref-type="table"}). The effect of overexpressing *rho-1* is not surprising because RHO-1 activity must be attenuated by RhoGAP activity in epidermal cells to control tension during elongation ([@bib19]). These findings suggest that the activity of CDC-42, like RHO-1, might be regulated to ensure proper embryo elongation.

###### Genetic interactions with *hmp-1*

  **Genotype**[^a^](#ttbl1n1){ref-type="table-fn"}   **Embryo survival (*n*)**   ***hmp-1* enhancement**[^b^](#ttbl1n2){ref-type="table-fn"}
  -------------------------------------------------- --------------------------- -------------------------------------------------------------
                                                     *%*                         
  Wild type                                          98 (555)                    N/A
  *gfp-cdc-42*                                       99 (387)                    N/A
  *gfp-rho-1*                                        99 (537)                    N/A
  *gfp-ced-10*                                       88 (566)                    N/A
  *hmp-1(fe4)*                                       48 (1248)                   N/A
  *hmp-1(fe4); gfp-cdc-42*                           19 (273)                    Yes
  *hmp-1(fe4); gfp-rho-1*                            19 (160)                    Yes
  *hmp-1(fe4); gfp-ced-10*                           46 (434)                    No
  *pac-1*                                            93 (866)                    N/A
  *hmp-1(fe4); pac-1*                                1 (633)                     Yes
  *hmp-1(fe4); pac-1; mCherry-pac-1*                 41 (444)                    No
  *hmp-1(fe4); pac-1; mCherry-pac-1(R984A)*          0 (479)                     Yes
  *picc-1*                                           97 (437)                    N/A
  *hmp-1(fe4); picc-1*                               14 (498)                    Yes
  *pac-1; picc-1*                                    92 (573)                    N/A
  *jac-1*                                            99 (641)                    N/A
  *hmp-1(fe4); jac-1*                                0 (726)                     Yes
  *jac-1; pac-1*                                     70 (918)                    N/A

All mutant alleles are functional nulls except the hypomorphic *hmp-1(fe4)* allele.

Yes, P \< 0.0001, using the Fisher exact test; No, P \> 0.01; N/A, not applicable.

RhoGAP PAC-1 localizes to AJs and regulates elongation {#s06}
------------------------------------------------------

To determine where CDC-42 might function to regulate elongation, we examined the localization of a functional HA-CDC-42 fusion protein ([@bib3]) within epidermal cells. HA-CDC-42 was enriched at the plasma membrane, including AJs, which we visualized by costaining for HMR-1 ([Fig. 3 A](#fig3){ref-type="fig"}). Because epidermal cell AJs must remodel as the cells change shape during elongation, and given the genetic interactions we observed between overexpressed *cdc-42* and *hmp-1(fe4)* mutants, we searched for candidate regulators of CDC-42 activity that localize to AJs. In early embryos, the RhoGAP PAC-1 (human ARHGAP21) interacts physically with proteins that bind to the cytoplasmic tail of HMR-1/E-cadherin, where it functions to inhibit CDC-42 activity and control cell polarity ([@bib3]; [@bib42]). A functional mCherry-PAC-1 fusion protein expressed from a recombineered fosmid was detected in epithelial cells and concentrated at junctions ([Fig. 3 B](#fig3){ref-type="fig"}). mCherry-PAC-1 colocalized nearly completely with HMR-1, but was significantly more apical than DLG-1, which is found basal to AJs (Fig. S4, A and B), indicating that PAC-1 is present at AJs. mCherry-PAC-1 also overlapped with the more broadly localized GFP-CDC-42 at AJs ([Fig. 3 D](#fig3){ref-type="fig"}), raising the possibility that PAC-1 inhibits a junctional pool of CDC-42 during elongation.

![**CDC-42, PAC-1, and PICC-1 localization at AJs.** (A) Superficial view of HA-CDC-42 and HMR-1 coimmunostaining in the dorsal epidermis of a bean-stage embryo. (B) Internal view of mCherry-PAC-1 and HMR-1 coimmunostaining in a bean-stage embryo showing mCherry-PAC-1 colocalization with HMR-1. (C) Internal view of mCherry-PAC-1 and PICC-1-GFP costaining showing colocalization at junctions. (D) Internal view of mCherry-PAC-1 and GFP-CDC-42 in a live bean-stage embryo. The boxed region of epidermal cells is shown in the inset below. Bars, 5 µm.](JCB_201611061_Fig3){#fig3}

If PAC-1 inhibits CDC-42, then *pac-1* mutants, similar to overexpressed *cdc-42*, should enhance the embryonic lethality of *hmp-1(fe4)* mutants. *pac-1(xn6)* contains a premature stop codon predicted to truncate the protein before the RhoGAP domain ([@bib3]). Although *pac-1(xn6)* mutants have defects in cell positioning during gastrulation, most embryos recover and hatch with normal morphology ([Fig. 4 B](#fig4){ref-type="fig"}, [Table 1](#tbl1){ref-type="table"}, and 2; [@bib3]). In contrast, *pac-1(xn6)* strongly enhanced the lethality of *hmp-1(fe4)* mutants ([Fig. 4 D](#fig4){ref-type="fig"} and [Tables 1](#tbl1){ref-type="table"} and S1). The majority of *hmp-1(fe4)*; *pac-1(xn6)* embryos elongated more slowly than *hmp-1(fe4)* or *pac-1(xn6)* single mutants ([Fig. 4 E](#fig4){ref-type="fig"}). For example, more than half of arrested *hmp-1(fe4)* mutant embryos reached the twofold stage or greater (Class III, 58%; [Fig. 4 F](#fig4){ref-type="fig"} and Video 6), whereas nearly all *hmp-1(fe4)*; *pac-1(xn6)* embryos arrested before the twofold stage of elongation (Class II, 97%; [Fig. 4 F](#fig4){ref-type="fig"}). Although *hmp-1(fe4)*; *pac-1(xn6)* embryos arrested early in elongation, all embryos completed ventral enclosure and arrested after the appearance of dorsal epidermal bulges ([Fig. 4 D](#fig4){ref-type="fig"}, arrow). The elongation phenotype of *hmp-1(fe4)*; *pac-1(xn6)* embryos was nearly as severe as that of *hmp-1(fe4)* embryos treated with *hmp-1* RNAi, which also formed dorsal bulges and arrested during, or just after, ventral enclosure (Fig. S3 D). The enhanced lethality of *hmp-1(fe4)*; *pac-1(xn6)* embryos was reversed to the level seen in *hmp-1(fe4)* alone by expressing wild-type mCherry-PAC-1 from a transgene, but was not affected by expressing comparable levels of mCherry-PAC-1(R984A), which contains a mutation that inactivates the RhoGAP domain ([@bib3]) without disrupting expression level or localization to AJs ([Table 1](#tbl1){ref-type="table"} and Fig. S5, A and B). Altogether, these findings indicate that the RhoGAP activity of PAC-1 is important for elongation and raise the possibility that PAC-1 regulates AJs by functioning as a RhoGAP that locally inhibits CDC-42.

![***pac-1*enhances *hmp-1(fe4)* during elongation.** (A--D) Stills from DIC time-lapse movies of wild-type, *pac-1*, and *hmp-1* mutant embryos and *hmp-1; pac-1* double mutant embryos. Red arrows indicate dorsal epidermal bulges. See Video 6. (E) Quantification of elongation rates for wild-type (*n* = 12), *pac-1* (*n* = 10), *hmp-1* (*n* = 7), and *hmp-1; pac-1* (*n* = 12) embryos. *t* = 0 min represents the comma stage, and values are the mean ± SD. (F) Phenotypic classes of *hmp-1* (*n* = 31) and *hmp-1; pac-1* (*n* = 32) mutant embryos. Data were pooled from three independent imaging experiments for each genotype. P-values were calculated using a Mann-Whitney *U* test. \*, P ≤ 0.05; \*\*\*, P ≤ 0.001. Bars, 5 µm.](JCB_201611061_Fig4){#fig4}

PAC-1 regulates elongation by inhibiting CDC-42 {#s07}
-----------------------------------------------

If PAC-1 inhibits CDC-42 through its RhoGAP activity, then CDC-42 should be overactive in embryos lacking PAC-1 activity. As an initial test of this hypothesis, we asked whether reducing *cdc-42* gene dosage rescued the enhanced lethality of *hmp-1(fe4)* caused by *pac-1* inactivation. Indeed, *hmp-1(fe4)*; *cdc-42/+* embryos were significantly less affected by *pac-1* RNAi than *hmp-1(fe4)* mutants ([Fig. 5 A](#fig5){ref-type="fig"}). This finding suggests that CDC-42 is overactive in *pac-1(RNAi)* embryos, and that overactive CDC-42 contributes to the lethality of *hmp-1(fe4) pac-1(RNAi)* embryos.

![***pac-1* inhibits junctional CDC-42 activity.** (A) Comparison of survival of embryos of the indicated genotypes, with the addition of control (empty vector) or *pac-1* feeding RNAi. Values are the mean ± SEM from three independent experiments; p-value was calculated using a two-tailed *t* test with Welch's correction. (B and C) CDC-42 biosensor localization in embryos treated with control (empty vector) RNAi or partial *cdc-42* RNAi. (D) Quantification of CDC-42 biosensor intensity at epidermal AJs in control embryos (*n* = 20), embryos overexpressing *mCherry-pac-1* (*n* = 15), or embryos overexpressing GAP-dead *mCherry-pac-1(R984A)* (*n* = 12). Individual data points from two independent experiments were pooled. Red bar and error bars are mean ± SD. P-values were calculated using a Mann-Whitney *U* test. \*\*\*, P ≤ 0.001; NS, P \> 0.05. Bars, 5 µm.](JCB_201611061_Fig5){#fig5}

To determine whether CDC-42 is active at AJs, we altered a maternally expressed biosensor consisting of the G protein--binding domain (GBD) of WSP-1/Wasp fused to GFP, which was shown to specifically report on CDC-42 activity ([@bib46]) by expressing it from *cdc-42* regulatory sequences. In epidermal cells, the CDC-42 biosensor concentrated at AJs ([Fig. 5 B](#fig5){ref-type="fig"}). Partial depletion of *cdc-42* by RNAi caused the biosensor to relocate from AJs to the cytoplasm and nucleus ([Fig. 5 C](#fig5){ref-type="fig"}), demonstrating that it reports on CDC-42 activity. In embryos overexpressing mCherry-PAC-1, biosensor levels at AJs were significantly decreased in comparison with embryos overexpressing GAP-dead mCherry-PAC-1(R984A) ([Fig. 5 D](#fig5){ref-type="fig"}). Altogether, these findings indicate that PAC-1 regulates the activity of CDC-42 at AJs to modulate elongation of the embryo.

PAC-1 likely functions with interacting linker protein PICC-1 {#s08}
-------------------------------------------------------------

At sites of contact between early embryonic cells, the coiled-coil protein PICC-1 (CCDC85A-C in humans) couples PAC-1 to HMR-1 by binding to both PAC-1 and the p120 catenin JAC-1 ([@bib42]). Mammalian CCDC85B (also known as DIPA) can interact with p120 and localizes to AJs, although its function is unknown ([@bib57]). To determine if PICC-1 might function with PAC-1 at epidermal cell AJs, we first examined the localization of a PICC-1-GFP fusion protein expressed from a recombineered genomic clone. PICC-1-GFP was present at AJs, where it colocalized with mCherry-PAC-1 ([Fig. 3 C](#fig3){ref-type="fig"} and Fig. S4 B).

Like *pac-1(xn6)* mutants, *picc-1(xn14)* null mutants are viable ([@bib42]; [Table 1](#tbl1){ref-type="table"}). Given that PAC-1 and PICC-1 have been shown to function together, we asked whether *picc-1* also interacts genetically with *hmp-1(fe4)*. Nearly all *hmp-1(fe4); picc-1(xn14)* and *hmp-1(fe4) picc-1(RNAi)* embryos arrested, and did so at a similar stage as *pac-1(xn6); hmp-1(fe4)* embryos ([Tables 1](#tbl1){ref-type="table"} and S1; Fig. S3, B and E; and Video 7). *pac-1(xn6); picc-1(xn14)* double mutants were also viable, like each single mutant, consistent with the genes functioning together in the same pathway ([Table 1](#tbl1){ref-type="table"}). Because PICC-1 links PAC-1 to JAC-1, we also examined genetic interactions between *jac-1* and *pac-1*. *jac-1(xn15)* null mutants are viable ([@bib42]) and enhanced the lethality of *hmp-1(fe4)* mutants to the same extent as *pac-1(xn6)* ([Tables 1](#tbl1){ref-type="table"} and S1), with embryos arresting before the twofold stage of elongation (Fig. S3, C and E). However, 30% of *jac-1(xn15); pac-1(xn6)* double null mutants died. Thus, whereas PAC-1 and JAC-1 may function together at AJs, one or both proteins likely have independent functions that are important for elongation.

AJ protein levels are increased in *pac-1* mutant embryos {#s09}
---------------------------------------------------------

Because PAC-1 localized to AJs and regulated elongation, we asked whether the localization or level of junction proteins was abnormal in embryos lacking *pac-1* function. To quantify protein levels, we used functional HMR-1-mCherry, JAC-1-GFP, and HMP-1-GFP fluorescent reporters expressed from transgenes in living embryos. Each protein concentrated at epidermal AJs in both wild-type and *pac-1(RNAi)* embryos. However, their levels at AJs were significantly increased in *pac-1(RNAi)* embryos relative to wild-type ([Fig. 6, A and B](#fig6){ref-type="fig"}; and Fig. S5 C). To confirm that the observed AJ protein increases were not limited to overexpressed transgenic proteins, we examined HMR-1-GFP expressed from a knockin allele ([@bib58]); HMR-1-GFP showed a similar increase in *pac-1(xn6)* mutants relative to wild-type (Fig. S5, D). In contrast with AJ proteins, the amount of DLG-1-GFP present at junctions was not increased in *pac-1(RNAi)* embryos ([Fig. 6 C](#fig6){ref-type="fig"}), consistent with the localization of DLG-1 to a separate junctional zone (Fig. S4).

![***pac-1*, *picc-1,* and *cdc-42* regulate AJ protein level.** (A--E) Quantitative intensity of fluorescently tagged AJ proteins in the indicated genetic background. Control embryos for RNAi experiments were treated with empty vector RNAi. "*cdc-42(CA)*" is epidermal overexpression of constitutively active HA-CDC-42. Intensity values were normalized such that the mean control value was 1. Individual data points from two independent experiments were pooled. (A) HMR-1-mCherry: control (*n* = 15) and *pac-1(RNAi)* (*n* = 15); (B) JAC-1-GFP: control (*n* = 15) and *pac-1(RNAi)* (*n* = 15); (C) DLG-1-GFP: control (*n* = 24) and *pac-1(RNAi)* (*n* = 21); (D) HMR-1-mCherry: control (*n* = 19) and *picc-1(RNAi)* (*n* = 19); (E) HMR-1-mCherry: control (*n* = 23) and *cdc-42(CA)* (*n* = 20). Red bars and error bars are mean ± SD. P-values were calculated using a Mann-Whitney *U* test. \*\*\*, P \< 0.0001; NS, P \> 0.05.](JCB_201611061_Fig6){#fig6}

Depletion of *picc-1* also caused an increase in junctional HMR-1-mCherry levels ([Fig. 6 D](#fig6){ref-type="fig"}), further suggesting that PAC-1 and PICC-1 function together. To determine whether the increase in AJ protein levels after loss of PAC-1 or PICC-1 could be caused by an increase in CDC-42 activity, we examined levels of HMR-1-mCherry in embryos expressing constitutively active CDC-42 specifically in the epidermis ("*cdc-42\[CA\]*" embryos; Fig. S5 E). HMR-1-mCherry remained concentrated at AJs in *cdc-42(CA)* embryos, but its levels were increased relative to wild-type ([Fig. 6 E](#fig6){ref-type="fig"}; compare with [Fig. 6 A](#fig6){ref-type="fig"}). We conclude that an increase in CDC-42 activity in epidermal cells is sufficient to augment levels of AJ proteins at junctions, suggesting that this is the basis for the increased AJ protein levels observed in *pac-1(RNAi)* and *picc-1(RNAi)* embryos.

CDC-42 activity levels affect junctional actin dynamics during elongation {#s10}
-------------------------------------------------------------------------

Because CDC-42 can also regulate actin polymerization, we analyzed junctional F-actin in *pac-1(xn6)* embryos. To determine whether junctional F-actin is aberrant, we expressed LifeAct-GFP within epidermal cells and captured high frame rate near--total internal reflection fluorescence (TIRF) movies during elongation ([Fig. 7](#fig7){ref-type="fig"}). In control embryos, actin filaments at AJs formed thick bundles that did not change their morphology ([Fig. 7 A](#fig7){ref-type="fig"} and Video 8). However, in *pac-1(xn6)* embryos, we observed multiple dynamic junction-associated actin extensions protruding in various directions from the junctional actin belt over the same imaging interval ([Fig. 7 B](#fig7){ref-type="fig"} and Video 8). To quantify actin dynamics, we calculated the SD of LifeAct-GFP intensity at each pixel throughout the imaging period, which was normalized to the mean pixel intensity to adjust for variation in transgene expression level. This value, displayed as a heat map in images ([Fig. 7, A--C](#fig7){ref-type="fig"}), reports on the dynamics of F-actin extensions at a given location. Compared with control embryos, F-actin in *pac-1(xn6)* mutant embryos was significantly more dynamic at epidermal AJs ([Fig. 7, B and D](#fig7){ref-type="fig"}). F-Actin also appeared less concentrated at junctions and significantly more dynamic in *cdc-42(MZ)* embryos ([Fig. 7, C and E](#fig7){ref-type="fig"}), suggesting that cycling of *cdc-42* activity is needed for proper F-actin organization and dynamics at AJs.

![***pac-1*and *cdc-42* regulate junctional actin morphology and dynamics.** (A--C, top) Near-TIRF high-resolution imaging of LifeAct-GFP in control, *pac-1* (see Video 8) and *cdc-42(MZ)* embryos at 1.3-fold elongation. Insets (middle) show the junctions between the seam cells (S) and ventral cells (V). Insets (bottom) are pseudo-colored images depicting actin dynamics (STDEV/AVERAGE values at each pixel) over the course of the movie (16 s: 512 time points imaging at 32 frames/s). (D and E) Junctional actin dynamics (STDEV/AVERAGE of pixel intensity over 512 time points, imaging at 32 fps) taken from a subset of junctions between seam and ventral cells, as depicted to the right from the graph (D). Embryos in (D) were 1.3-fold: control (*n* = 23), *pac-1 (n* = 20); embryos in (E) were 1.2-fold: control (*n* = 13), *cdc-42(MZ)* (*n* = 17). Each data point shows the average value for one embryo. Individual data points from two independent experiments were pooled for each data set. Red bars and error bars are mean ± SD. P-values were calculated using a Mann-Whitney *U* test. \*\*\*, P \< 0.001. (F--H, top) CFBs in control, *hmp-1(fe4),* and *hmp-1(fe4); pac-1* embryos. Insets (bottom) show the CFBs in dorsal cells (labeled D) and disconnection of CFBs (arrowheads) from the junction with seam cells (S). Blue dashed line depicts the junction between dorsal (D) and seam (S) cells. Bars, 5 µm.](JCB_201611061_Fig7){#fig7}

At a later stage of elongation (beginning at the ∼1.7-fold stage), actin fibers in dorsal and ventral cells become reorganized into circumferential bundles (CFBs; [Fig. 7 F](#fig7){ref-type="fig"}; [@bib14]). At this stage, AJs in *pac-1(xn6)* embryos no longer exhibited ectopic actin extensions (data not depicted). Thus, *pac-1* inactivation causes a transient increase in dynamic junctional F-actin extensions during the early stages of elongation---when *pac-1(xn6)* mutant embryos in the *hmp-1(fe4)* sensitized background arrest. In 18 of 18 *hmp-1(fe4); pac-1(xn6)* embryos imaged during elongation, circumferential actin bundles were visibly detached from junctions ([Fig. 7 H](#fig7){ref-type="fig"}), and sites of detachment corresponded to regions where bulges of epidermis formed on the dorsal surface. Separation of circumferential actin bundles from AJs occurs in *hmp-1* null mutant embryos ([@bib14]), and to a much lesser extent in *hmp-1(fe4)* hypomorphic mutant embryos ([@bib67]; [Fig. 7 G](#fig7){ref-type="fig"}), and likely explains why *hmp-1(fe4); pac-1(xn6)* embryos fail to elongate.

Discussion {#s11}
==========

As a direct regulator of PAR polarity proteins, actin polymerization factors, and vesicle trafficking proteins ([@bib55]), CDC-42 is positioned to control diverse cell biological events that are critical to AJ formation and remodeling. Here, we have taken advantage of two strengths of *C. elegans* embryos---the ability to remove CDC-42 function acutely before epithelial cells form, and the capability to visualize the dynamics of junction proteins and associated actin microfilaments in living embryos---to define how CDC-42 contributes to junction formation and remodeling during epithelial morphogenesis. Our findings provide two new insights into CDC-42 function and regulation. First, we show that *cdc-42* mutant epidermal cells are able to polarize and undergo junction maturation normally during MET, contrasting with interpretations from studies in several other systems. Second, we identify a conserved pathway containing the RhoGAP PAC-1/ARHGAP21 and its binding partner PICC-1/CCDC85A-C, which inhibits CDC-42 activity at AJs ([Fig. 8](#fig8){ref-type="fig"}). We show that PAC-1, PICC-1, and appropriate CDC-42 activity are important for proper junctional actin organization and levels of AJ proteins, and contribute to the fidelity of epidermal cell shape changes.

![**Model for PAC-1 inhibition of CDC-42 at AJs.** See Discussion text for details. Different populations of actin are shown, including junctional actin and CFBs, which align apically to connect one side of the cell to another.](JCB_201611061_Fig8){#fig8}

Cdc42 and epithelial polarity {#s12}
-----------------------------

Numerous studies that examined cultured epithelial cell lines or fixed tissues in genetic model organisms have concluded that *cdc-42* is required for epithelial cell polarization. For example, in the early *Drosophila* embryo, expressing dominant-negative Cdc42 blocks apicobasal polarization of the blastoderm epithelium ([@bib36]). Similarly, conditional *Cdc42* knockout in several mammalian cell types, including 3D-cultured MDCK cells, mouse mammary epithelial cells, the developing kidney, and pancreatic epithelial cells, results in defective apicobasal polarity of tubular epithelia ([@bib59]; [@bib41]; [@bib23]; [@bib20]). However, these and other studies did not examine the initial stages of epithelial polarization as it unfolded using time-lapse microscopy, leaving it unclear whether the observed polarity phenotypes result from a failure to initially establish polarity, or rather a rapid loss of polarity caused by defects in its maintenance. Here, we addressed the role of CDC-42 in polarizing *C. elegans* epithelial cells by removing CDC-42 protein acutely from embryos *before* precursor cells differentiate into epithelia, and observing polarization and junction maturation live using fluorescent time-lapse microscopy of polarity and junction proteins (HMR-1, DLG-1, PAR-3). These results demonstrate that CDC-42 is dispensable for the epithelia we examined (epidermis and intestine) to establish apicobasal polarity or to form mature junctions. The only defects we noted were a reduced level of apical PAR-6 and PAR-3 enrichment in epidermal cells, although both proteins were still apically localized. To confirm these results and to rule out the possibility that trace amounts of CDC-42 might remain in *cdc-42(MZ)* mutants to facilitate polarization, we examined the localization of a CRIB mutant form of PAR-6 unable to bind to CDC-42 ([@bib1]). CRIB mutant PAR-6 still accumulated apically in polarizing epithelia, albeit with reduced apical enrichment in epidermal cells, similar to endogenous PAR-6 in *cdc-42(MZ)* mutants. A previously published examination of intestinal PAR-6 in larvae partially depleted of *cdc-42* using RNAi, as well as of embryos expressing maternal CRIB mutant PAR-6 (in *par-6(+)* embryos), made similar observations (partial loss of apical PAR-6) and concluded that CDC-42 was required for PAR-6 apical accumulation ([@bib79]). However, these studies are consistent with our observations using embryos entirely lacking CDC-42 protein, or expressing CRIB mutant PAR-6 in the absence of endogenous PAR-6, and point to a partial requirement for CDC-42 in apical PAR-6 accumulation as well as a redundant, CDC-42--independent mechanism for PAR-6 localization that does not use the CRIB domain. Our findings therefore indicate that CDC-42 is not required for polarity establishment or junction formation in *C. elegans* epidermal and intestinal epithelial cells.

What might explain the differences we observe in *C. elegans* embryonic epithelia and epithelia in other model systems that depend on Cdc42 for polarity? One possibility is that some cells use alternative or redundant polarization pathways. This may very well be the case, as there is increasing evidence that "core" epithelial polarity proteins, for example PAR-3, are required for polarization of some epithelial cell types but not others, even within the same organism ([@bib2]). Moreover, deletion of *Cdc42* from some cell types, such as keratinocytes or embryonic stem cell--derived endothelial cells, does not inhibit AJ formation ([@bib24]; [@bib70]). A formal possibility is that one or more *C. elegans* Racs function redundantly with CDC-42 in polarization, because in mammals, Rac also binds the PAR-6 CRIB domain ([@bib37]; [@bib38]; [@bib53]; [@bib71]). However, it is unknown whether this interaction occurs in *C. elegans*, and because CRIB mutant PAR-6 still enriches apically, this interaction would have to use a different mechanism than the CDC-42--PAR-6 interaction. An alternative and nonexclusive possibility is that CDC-42 is required only for the maintenance of epithelial junctions (a conserved role---see next section), which in different cell types and organisms have varying degrees of importance in maintaining polarity. For example, early mouse embryos lacking E-cadherin show strong polarity defects, whereas E-cadherin is not needed for polarity in *C. elegans* epithelia, and is needed for polarity maintenance but not establishment in the *Drosophila* blastoderm ([@bib34]; [@bib82]; [@bib90]). Studies in other model systems, in particular cells lacking *cdc-42* before they undergo MET and examined by fluorescence time-lapse imaging, will be needed to help resolve these possibilities.

CDC-42 and junction regulation {#s13}
------------------------------

CDC-42 has a conserved role in trafficking AJ proteins and regulating actin polymerization at junctions, helping to ensure an appropriate balance between cell adhesion and junction remodeling during morphogenetic events. Here, we showed that loss of CDC-42 affects junction integrity, and alters actin organization and dynamics at AJs. One class of *cdc-42(MZ)* mutant embryos arrested before, or just after, completion of ventral enclosure. This finding suggests that CDC-42 may contribute to the migration of epidermal cell sheets, or to the genesis of new epidermal AJs that form at the ventral surface as ventral enclosure completes. Both processes might be affected by the changes in actin morphology and dynamics that we observed in *cdc-42* mutants. Our observations are consistent with a study showing that loss of the RhoGAP *rga-7*, which can regulate CDC-42 activity, causes defects in ventral enclosure ([@bib66]). However, in contrast with *pac-1*, *rga-7* does not appear to inhibit CDC-42 activity, but rather contributes to the localization of active CDC-42 clusters along junctions of migrating epidermal cells ([@bib66]). Another study identified defects in epidermal cell intercalations in embryos with compromised CDC-42 activity, pointing to a potential role in junction regulation or cell movement ([@bib92]).

A second class of *cdc-42(MZ)* mutants completed ventral enclosure and arrested at variable stages of elongation. We consider it unlikely that these elongation defects are an indirect consequence of ventral enclosure defects, because failure to properly form junctions at the ventral surface upon the completion of ventral enclosure typically leads to rupture at the beginning of elongation ([@bib14]). In addition, our analysis of overexpressed *gfp-cdc-42*, *pac-1* mutants, and *picc-1* mutants in the *hmp-1(fe4)* background, revealed roles primarily in elongation but not ventral enclosure. We propose that CDC-42 contributes to both events, and that distinct regulators may be used during ventral enclosure and elongation to control CDC-42 activity sequentially.

Increasing the activity of junctional CDC-42 augmented levels of HMR-1 and its associated catenins at AJs, and also resulted in aberrant junctional F-actin organization and dynamics. Because CDC-42 effectors include proteins that regulate trafficking as well as those that control actin polymerization ([@bib33]), it is possible that these phenotypes are uncoupled and arise independently. Alternatively, given that F-actin is involved in vesicle trafficking and that AJs directly link to junctional microfilaments, it is feasible that the two phenotypes are coupled. It is also unclear whether it is the increase in junction protein levels, and/or the disorganization of F-actin at junctions, that causes elongation defects in *hmp-1(fe4); pac-1* mutants. For example, overexpression of *Drosophila* E-cadherin inhibits tracheal development ([@bib80]) and wound repair ([@bib35]), and inhibition of E-cadherin endocytosis results in cell intercalation defects in the early *Drosophila* embryo ([@bib52]). In addition, depleting actin-bundling protein EEF1A in human keratinocytes, which augments the actin turnover rate and increases junctional E-cadherin levels, leaves junctions more sensitive to mechanical stress ([@bib25]). These and other studies indicate that increased levels of E-cadherin at junctions do not necessarily indicate that junctions are "stronger." Given the altered organization and dynamics of F-actin at junctions that we observed in *pac-1* mutants, it is also likely that F-actin cannot connect as efficiently to AJs as in wild-type embryos.

PAC-1 and PICC-1 homologues localize to AJs in mammals ([@bib81]; [@bib57]; [@bib88]), and the PAC-1 homologue ARHGAP21 has been shown to inhibit CDC-42 in cultured cells ([@bib8]), suggesting that these proteins have deeply conserved roles in regulating junctional CDC-42. Although the in vivo functions of mammalian PAC-1 (ARHGAP21 and ARHGAP23) and PICC-1 (CCDC85A, CCDC85B, and CCDC85C) homologues have not yet been determined, a mutation in mouse *Ccdc85C* is associated with hemorrhagic hydrocephalus. CCDC85C protein localizes to apical junctions in radial glia lining brain ventricles ([@bib62]), raising the possibility that this birth defect results from improper regulation of AJ proteins or junctional actin during brain development.

Materials and methods {#s14}
=====================

Genetics {#s15}
--------

Worm strains used in this study are listed in Table S2.

Transgene construction {#s16}
----------------------

### mCherry-pac-1(R984A) {#s17}

*mCherry-pac-1(R984A)* was created by recombineering the R984A mutation into *mCherry-pac-1* in the fosmid clone WRM063aE11 ([@bib42]).

### cdc42P::gfp-zf1-rho-1 {#s18}

*cdc42P::gfp-zf1-rho-1* was created using Gateway cloning. Destination vector pJN406, which includes the *cdc-42* promoter, *gfp-zf1*, and *unc-119(+)* ([@bib3]), was used with an entry clone containing a full-length *rho-1* cDNA, corresponding to WormBase transcript *Y51H4A.3a*.

### par6P::par-6-ΔCRIB-gfp {#s19}

*par6P::par-6-ΔCRIB-gfp* was created by cloning an *Nsi*I *Stu*I restriction fragment from the *pie-1P::par-6-CM2-GFP* plasmid ([@bib1]) into the same sites of a plasmid expressing *par-6-gfp* from endogenous regulatory sequences ([@bib63]). The *unc-119(+)* gene from plasmid pJN254 ([@bib63]) was inserted into the vector NotI site.

All other transgenes were assembled using Gibson cloning ([@bib30]):

### cdc42P::gst-gfp-wsp-1^gbd^ {#s20}

*cdc42P::gst-gfp-wsp-1^gbd^* was assembled from vector pJN405, which includes *unc-119(+)* and *cdc-42P*; *gst,* amplified from pGEX-4T-1; and *gfp-wsp-1^gbd^,* amplified from worm strain WH0363 (a gift from K. Kumfer, University of Wisconsin, Madison, WI; [@bib46]).

### cdc42P::mCherry-ha-ha-pac-1 {#s21}

*cdc42P::mCherry-ha-ha-pac-1* was assembled using vector pJN566 ([@bib6]); *cdc-42P* promoter amplified from pJN405; and *pac-1* cDNA amplified from pDA7 (*pie-1P::gfp-pac-1*; [@bib3]).

### cdc42P::mCherry-ha-ha-pac-1(R984A) {#s22}

*cdc42P::mCherry-ha-ha-pac-1(R984A)* was assembled in the same manner as *cdc42P::mCherry-ha-ha-pac-1,* except the *pac-1(R984A)* sequence was amplified from pDA8 \[*pie-1P::gfp-pac-1(R984A)*\] ([@bib3]).

### lin-26P::ha-ha-cdc-42(Q61L) {#s23}

*lin-26P::ha-ha-cdc-42(Q61L)* was assembled using vector pJN566 ([@bib6]); a 4.1-kb *lin-26* promoter ([@bib48]); and *ha-ha-cdc-42(Q61L)* amplified from *hsp-16P::ha-cdc-42(Q61L)* ([@bib3]).

### lin-26P::gfp-nls {#s24}

*lin-26P::gfp-nls* was assembled using vector pJN566 ([@bib6]) and the 4.1-kb *lin-26* promoter ([@bib48]). The NLS was added to *gfp* within a primer used for Gibson assembly: 5′-TGGCATGGATGAACTATACAAA*atgaccgctccaaagaagaaacgcaaagtaccggtagaaaaa*TAGAACCCAGCTTTCTTGTACAAAG-3′ (NLS is in italics).

### lin-26P::LifeAct-GFP {#s25}

*lin-26P::LifeAct-GFP* was assembled using vector pJN566 ([@bib6]) and the 4.1-kb *lin-26* promoter ([@bib48]). LifeAct coding sequences ([@bib74]) were inserted between the promoter and *gfp* within a primer used for Gibson assembly: 5′-*ATGGGAGTTGCTGATCTTATTAAAAAATTCGAATCTATTTCTAAAGAAGAA*ATGTATCAATCGTCTTCTTCATCTCCAT-3′ (*LifeAct* sequence is in italics).

### CRISPR knockins {#s26}

Plasmids for CRISPR/Cas9 genome editing to make *par-6(xn60: par-6-zf1-yfp + unc-119)* and *cdc-42(xn65: zf1-yfp-cdc-42 + unc-119)* were constructed as described previously ([@bib18]), with the following modifications. For *par-6,* the guide RNA sequence from plasmid pDD122 was replaced with the sequences (5′-GCACCGCAGCCGCTACAGG-3′) and (5′-GTCCACCTGTAGCGGCTGCGG-3′) to create two single guide RNAs (sgRNAs) that cleave near the *par-6* C-terminus (plasmids pJA031 and pJA032). For *cdc-42,* the sequence (5′-GCCGTCACAGTAATGATCGG-3′) was used in pDD122 to direct cleavage near the *cdc-42* N-terminus (plasmid pJA037). Homologous repair plasmids for *par-6* (pJA034) and *cdc-42* (pJA036) were constructed using Gibson assembly. For *par-6*, the following DNA segments were assembled in order: 1517 bp upstream of *par-6* stop codon (including six silent point mutations adjacent to the predicted sgRNA cut sites) as the left homology arm; *zf1-yfp* with *unc-119*; and the 3′-terminal 1508 bp of *par-6* genomic sequence as the right homology arm. For *cdc-42*, the repair plasmid contained the following DNA segments: the 5′-terminal 1511 bp of *cdc-42* genomic sequence as the left homology arm; *zf1-yfp* with *unc-119*; and 1502 bp downstream of the *cdc-42* start codon as the right homology arm (including five silent point mutations adjacent to the predicted sgRNA cut sites), and was amplified from WS5018 strain genomic DNA to include 5′ linker sequence ([@bib64]). *zf1-yfp* with *unc-119* flanked by LoxP sites was amplified from plasmid pJN601, which contains LoxP-flanked *unc-119* inserted in reverse orientation into a synthetic intron within *yfp* ([@bib7]). The vector backbone for each construct was PCR-amplified from pJN601 using Gibson assembly primers that overlapped with homology arms for *par-6* or *cdc-42*.

*par-6(xn60: par-6-zf1-yfp + unc-119)* was generated by microinjecting the sgRNA plasmids pJA031 and pJA032 (which also contains *Cas9*), the homologous repair template pJA034, and plasmid coinjection markers pGH8 (*rab-3P::mCherry::unc-54utr*; plasmid 19359; Addgene), pCFJ104 (*myo-3P::mCherry::unc-54utr*; plasmid 19328; Addgene), pCFJ90 (*myo-2P::mCherry::unc-54utr*; plasmid 19327; Addgene), and pMA122 (*peel-1* negative selection; plasmid 34873; Addgene) into *unc-119(ed3)* mutant worms ([@bib28]; [@bib18]). Plates containing non-Unc F~2~ transformants were heat-shocked at 34°C for 4 h to activate PEEL-1 toxin in array-bearing animals, and successfully edited F~2~ non-Unc animals were confirmed by the absence of mCherry expression in the F~2~ generation and YFP expression in their progeny. *cdc-42(xn65: zf1-yfp-cdc-42 + unc-119)* was generated using the same procedure, but with *cdc-42* sgRNA and repair construct. Both knockin alleles were functional, but caused a low level of lethality (*par-6 \[xn60\]*, 88% \[387/439\] viable; *cdc-42\[xn65\]*, 85% \[258/305\] viable).

Worm transformation {#s27}
-------------------

*cdc42P::gfp-zf1-rho-1, mCherry-pac-1(R984A),* and *cdc42P::gst-gfp-gbd(wsp-1)* were integrated into *unc-119(ed3)* worms using biolistic transformation ([@bib69]).

The following transgenes were injected into wild-type worms to produce extrachromosomal arrays ([@bib61]): *cdc42P::mCherry-ha-ha-pac-1* (10 ng/µl + 80 ng/µl pRF4); *cdc42P::mCherry-ha-ha-pac-1(R984A)* (10 ng/µl + 80 ng/µl pRF4)*; lin-26P::ha-ha-cdc-42(Q61L)* (1 ng/µl + 90 ng/µl pRF4); and *lin-26P::nls-gfp* (1 ng/µl + 90 ng/µl pRF4). pRF4 contains the dominant *rol-6(su1006)* allele ([@bib61]).

*cdc-42(MZ)* embryos {#s28}
--------------------

### Strategy I (Fig. S1 C) {#s29}

*cdc-42(gk388)/cdc-42(gk388); xnIs83 (ha-ha-zf1-ha-cdc-42)/+* hermaphrodites were allowed to self-fertilize; 25% of F2 progeny are expected to be *cdc-42(MZ)*: *cdc-42(gk388)* mutant embryos that express maternal HA-HA-ZF1-HA-CDC-42 only in very early embryos before it is degraded. *cdc-42(MZ)* were distinguished from the control embryos by staining with anti-HA antibody or by single-embryo PCR genotyping using primers 5′-GCAAGTTGTTTGGTACGGAAAACCG-3′ and 5′-TGCATAGTCTGGCACGTCGTATG-3′.

### Strategy II (Fig. S1 D) {#s30}

*cdc-42(gk388)/cdc-42(xn65: zf1-yfp-cdc-42)* hermaphrodites were allowed to self-fertilize; 25% of F2 progeny are expected to be *cdc-42(MZ)*: *cdc-42(gk388)* mutants that express maternal YFP-ZF1-CDC-42 only in very early embryos before it is degraded. *cdc-42(MZ)* were distinguished from rescued control embryos by the absence of YFP-ZF1-CDC-42. Genotyping of *cdc-42(MZ)* embryos also carrying a *gfp* transgene was performed on the SP5 confocal, capturing narrow bandpass emission after 488-nm (GFP) and 514-nm (YFP) excitation to separate the fluorescent proteins.

*par-6(MZ)* embryos {#s31}
-------------------

*par-6(MZ); par-6Δcrib-gfp* embryos were obtained by allowing *par-6(tm1425)/par-6(xn60: par-6-zf1-yfp); par-6Δcrib-gfp/+* hermaphrodites to self-fertilize; 25% of F2 embryos are expected to be *par-6(MZ)*: *par-6(tm1425)/par-6(tm1425)* that express maternal PAR-6-ZF1-YFP only during very early embryonic stages*;* 75% of these mutants should have the *par-6Δcrib-gfp* transgene. *par-6(MZ)* embryos were distinguished from control sibling embryos by the absence of PAR-6-ZF1-YFP.

Western blots {#s32}
-------------

100 synchronized young adult worms were picked into M9 buffer, placed on a rotator, and washed once an hour for five hours. The worm pellet was frozen in liquid nitrogen and thawed on ice, and 50 µl 2 × LDS sample buffer (Invitrogen) containing 200 mM dithiothreitol was added. Samples were vortexed until worm corpses were completely dissolved. The lysate was heated at 90°C for 10 min and centrifuged. Lysates were loaded in 10% Bis-Tris SDS-PAGE gels (Invitrogen) for immunoblot analysis. Primary antibodies used for analysis were mouse anti--α-tubulin 1:30,000 (clone B-5-1-2; Sigma-Aldrich) and rat anti-RFP 1:1,000 (clone 5F8; <http://antibodies-online.com>). Primary antibodies were detected with HRP-conjugated secondary antibodies and the ECL Prime kit (Amersham).

RNAi {#s33}
----

For *jac-1* RNAi, base pairs 1546 to 2640 corresponding to WormBase transcript *Y105C5B.21b* were cloned into vector pPD129.36 ([@bib84]). For *hmp-1* RNAi, base pairs 2163 to 2856 of WormBase transcript *R13H4.4a* were cloned into vector pPD129.36. For *pac-1* RNAi, base pairs 3706 to 4585 of Wormbase transcript *C04D8.1a* were used, corresponding to the C04D8.1 feeding library clone ([@bib39]). For *picc-1* RNAi, 1.6 kb corresponding to the entire WormBase transcript *F29G9.2a* was cloned into pPD129.36. For *cdc-42* RNAi, the entire *cdc-42* coding sequence (Wormbase *R07G3.1* transcript) in vector pPD129.36 was used ([@bib1]).

RNAi constructs were transformed into *Escherichia coli* strain HT115, and experiments were performed using the feeding method ([@bib85]). L4 larvae were placed on RNAi plates seeded with bacterial cultures grown for 8--9 h at 37°C in selective media. Seeded plates were left at room temperature for 12--20 h for induction. Empty vector pPD129.36 was used as a negative control in all experiments. Worms were fed for 36--40 h at 25°C, and were either transferred to new RNAi plates to lay eggs (to assay embryonic lethality) or chopped for fixation and staining of embryos. For *cdc-42* RNAi, embryos were examined after 30 h of feeding at 20°C.

Each RNAi experiment included a control with GFP- or mCherry-fused target protein to check for knockdown efficiency.

Determining embryonic lethality {#s34}
-------------------------------

Seven to ten adult worms were placed on seeded plates and allowed to lay eggs for six hours at 23°C. Worms were subsequently removed, and eggs were counted. After 24 h, the number of unhatched eggs was counted. Experiments were performed in triplicate.

Immunostaining {#s35}
--------------

Embryos were placed in 7 µl water on poly-[l]{.smallcaps}-lysine--coated slides, freeze-cracked on dry ice, fixed in methanol and paraformaldehyde, and stained as described ([@bib3]). The following primary antibodies and dilutions were used: rabbit anti-HMR-1 1:10,000 ([@bib42]), mouse anti--HMP-1 1:10 ([@bib14]), mouse anti--PSD-95 (recognizes DLG-1) 1:200 (Affinity BioReagents), rabbit anti-GFP 1:1,000 (Ab6556.25; AbCam), rat anti-mCherry 1:100 (clone 5F8; <http://antibodies-online.com>), rabbit anti--PAR-6 1:20 ([@bib78]), mouse anti-HA 1:1,000 (clone 16B12; Covance), and rabbit anti--LET-413 1:5,000 ([@bib4]). The following secondary antibodies were used: Alexa Fluor 488 anti-rabbit IgG (H+L) 1:1,000 (Molecular Probes), Cy3 anti-rat 1:100 (Jackson ImmunoResearch), Cy3 anti-mouse IgG (subclasses 1+2a+2b+3) 1:250 (Jackson ImmunoResearch), Alexa Fluor 647 anti-mouse IgG (H+L) 1:100 (Jackson ImmunoResearch), and Alexa Fluor 647 anti-rabbit 1:200 (Molecular Probes).

Embryo mounting {#s36}
---------------

For live imaging, embryos were mounted on 4% agar pads. For scoring elongation phenotypes and rates, multiple two-cell embryos were mounted together, allowed to develop for 3 h at room temperature, and imaged simultaneously in the same field of view. *cdc-42(MZ)* embryos were imaged together with control embryos in the same field of view until control embryos hatched. For LifeAct-GFP near-TIRF imaging, embryos were mounted in ∼4 µl H~2~O containing 100--150 polystyrene beads (14.92 µm diameter; NT29N; Bangs Labs) to flatten the embryo surface.

Imaging {#s37}
-------

DIC movies were acquired using an AxioImager (Zeiss), 63× 1.4 NA or 40× 1.3 NA objective, DIC optics, an Axiocam MRM camera, and AxioVision software. Timelapse images were acquired every 3 min for 7--9 h at 23°C, with six *z*-planes spaced at 2-µm intervals.

Fluorescence images for [Fig. 3](#fig3){ref-type="fig"} (B and D), Fig. S1 (A--C), Fig. S2 (A--D), Fig. S4 A, and Fig. S5 E were acquired on an AxioImager with 63× 1.4 NA or 40× 1.3 NA objective and a camera (model [C10600](https://www.ncbi.nlm.nih.gov/nucest/1535671)-10B-H, S. 160522; Hamamatsu). Images were deconvolved using the constrained iterative method in AxioVision software. The sum of 7--10 *z*-sections taken at 0.3-µm intervals is shown. All other fluorescent images (except LifeAct-GFP) were acquired using an SP5 confocal microscope (Leica), 63× 1.4 NA oil-immersion objective for fixed samples, 63× 1.2 NA water-immersion lens for live imaging, 488-, 561-, 594-, or 633-nm laser, 4× zoom, and 0.7-µm *z*-interval. For intensity measurements, 1.5-fold live embryos were imaged using HyD detectors and the photon-counting mode.

LifeAct-GFP images were acquired on an inverted Eclipse-Ti microscope (Nikon) with TIRF illuminator and Perfect Focus, 488 nm laser, 100× 1.49 NA oil-immersion objective, iXon3 897 EMCCD camera (Andor) with a ET525/50M filter (Chroma Technology). Laser illumination angle and intensity were controlled by NIS-Elements Software (Nikon). For near-TIRF imaging ([@bib75]), the laser illumination angle was the same for all experiments and was chosen to achieve the highest signal intensity with nearly even illumination. Images were magnified by 1.5× and taken at 32 frames/s.

Image analysis {#s38}
--------------

All measurements were performed using ImageJ (National Institutes of Health). For measuring elongation rates, the length of the eggshell was determined and used as a reference for onefold elongation. The zero time point for all measurements was at the bean stage.

For the intensity profile in [Fig. 2 E](#fig2){ref-type="fig"}, a line one pixel in width and 3 µm in length length was drawn perpendicular to the apical epidermal membrane as shown in [Fig. 2 (A and B)](#fig2){ref-type="fig"}. The intensity of each pixel along the line was plotted using the Plot Profile ImageJ plug-in.

The apical membrane to cytoplasm intensity ratio in epidermal cells was measured in bean-stage embryos. A single focal plane image was selected from a z-stack. A line one pixel in width and 20 µm in length was drawn along the apical membrane, and a second line was drawn in the cytoplasm ∼2 µm below the apical membrane, as shown in [Fig. 2 F](#fig2){ref-type="fig"}. Mean pixel intensity values along each line were calculated using the ImageJ measuring tool. Each data point on the graph represents the ratio between the mean intensity value at the apical membrane divided by the mean intensity value in the cytoplasm measured for one embryo.

The junctional to lateral intensity ratio for HMR-1-GFP ([Fig. 2 J](#fig2){ref-type="fig"}) was measured by drawing a line along the lateral membrane and then dividing the intensity measured in the junctional area by the mean intensity along the lateral domain.

Pearson correlation coefficient colocalization tests were performed on deconvolved images using the JACoP plug-in in ImageJ.

The efficiency of degradation of YFP-ZF1-CDC-42 was quantified in the epidermis of 1.5-fold embryos. Photon counting mode on the Leica SP5 confocal was used for imaging. Embryos were selected using the freehand selection tool on an image produced by *z*-projection of two confocal z-sections. Background intensity was subtracted from the mean intensity value.

The intensity of AJ components at junctions was measured at the 1.5-fold stage. A *z*-projection of the sum of the three top *z*-sections was measured for each embryo. A duplicate of this image was used to create a mask, which was filtered with an FFT Bandpass filter (to filter out structures smaller than two pixels) and thresholded. The mask was then used to select junctions on original nonprocessed image for measurement. The "Analyze Particles" plug-in was used to measure intensities.

The intensity of the CDC-42 biosensor at junctions was measured at the 1.5-fold stage by drawing a line across the junction and measuring the maximal intensity. For each embryo, four measurements were taken.

LifeAct-GFP images in [Fig. 7](#fig7){ref-type="fig"} were obtained by averaging 200 frames and applying the Unsharp Mask filter (radius 1 pixel and mask weight 0.7). In [Fig. 7 D](#fig7){ref-type="fig"}, embryos at the same developmental stage (1.3-fold elongation) and in the same orientation (lateral and ventral rows of cells up) were analyzed. In [Fig. 7 E](#fig7){ref-type="fig"}, embryos at 1.2- and 1.3-fold elongation were analyzed. An image stack of 512 time points was processed by running a mean of 16 frames to reduce noise, using linear contrast enhancement with no saturated pixels, and subtracting background. SD was calculated for each pixel through time and then divided by a mean intensity of this pixel to normalize. The output of this calculation was an image that was pseudo-colored as a heat map using LUT. To measure actin remodeling at the junctions, a segmented line 1 µm in width was drawn along the junction between two ventral cells (18 and 20, Worm Atlas) and their neighboring seam cells.

For plotting image quantification and statistical analysis, mean values for each embryo were copied to Prism 6.

Statistics {#s39}
----------

Statistical analysis was performed in GraphPad Prism 6. Statistical tests, number of embryos, and number of experiments are indicated in the figure legends. No statistical method was used to predetermine the sample size. The investigators were not blinded during experiments and outcome assessment.

Online supplemental material {#s40}
----------------------------

Fig. S1 shows strategies for obtaining *cdc-42* mutants. Fig. S2 shows markers of polarization and junction maturation in *cdc-42(MZ)* embryos. Fig. S3 shows elongation and arrest phenotypes of embryos in genetic interaction experiments. Fig. S4 shows quantification of PAC-1 colocalization with junction proteins. Fig. S5 shows expression of GAP-dead PAC-1 and constitutively active CDC-42, and additional quantification of AJ protein levels in *pac-1(xn6)* embryos. Table S1 shows genetic interactions between *hmp-1(fe4)* embryos and embryos treated with indicated RNAi. Table S2 shows the list of strains used in this study. Video 1 shows elongation in control and *cdc-42* embryos. Video 2 shows junction formation and maturation of HMR-1-GFP in control and *cdc-42* embryos. Video 3 shows polarization of HMR-1-GFP in the intestine of control and *cdc-42* embryos. Video 4 shows junction maturation of DLG-1-RFP in control and *cdc-42* embryos. Video 5 shows elongation in a *hmp-1(fe4); gfp-cdc-42* embryo. Video 6 shows elongation in control, *pac-1(xn6)*, *hmp-1(fe4)*, and *hmp-1(fe4); pac-1(xn6)* embryos. Video 7 shows elongation in a *hmp-1(fe4); picc-1* embryo. Video 8 shows junctional actin dynamics in control and *pac-1(xn6)* embryos.
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